Skip to content
10-Q

Quarterly Report

Cadrenal Therapeutics, Inc. CVKD

0001213900-25-107816

← back to feed
Filed
Nov 10, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 10, 2025 2.08M sh
Shares Diluted Q3 2025 · Sep 30, 2025 2.04M sh
Shares Diluted Q3 2025 · Sep 30, 2025 1.95M sh
Shares Diluted Q3 2025 · Sep 30, 2024 1.1M sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 1.23M sh
Capex Q3 2025 · Sep 30, 2025 $5.1K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$10.03M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$5.57M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $3.86M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $10.02M
Stockholders Equity Q3 2025 · Sep 30, 2025 $2.73M
Stockholders Equity Q3 2025 · Jun 30, 2025 $4.3M
Stockholders Equity Q3 2025 · Dec 31, 2024 $7.44M
Stockholders Equity Q3 2025 · Sep 30, 2024 $3.41M
Stockholders Equity Q3 2025 · Jun 30, 2024 $3.99M
Stockholders Equity Q3 2025 · Dec 31, 2023 $7.69M
Current Liabilities Q3 2025 · Sep 30, 2025 $1.35M
Current Liabilities Q3 2025 · Dec 31, 2024 $2.68M
Total Liabilities Q3 2025 · Sep 30, 2025 $1.35M
Total Liabilities Q3 2025 · Dec 31, 2024 $2.68M
Current Assets Q3 2025 · Sep 30, 2025 $4.08M
Current Assets Q3 2025 · Dec 31, 2024 $10.11M
Total Assets Q3 2025 · Sep 30, 2025 $4.09M
Total Assets Q3 2025 · Dec 31, 2024 $10.12M
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.31
Eps Diluted Q3 2025 · Sep 30, 2025 −$5.23
Eps Diluted Q3 2025 · Sep 30, 2024 −$2.18
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$5.24
Eps Basic Q3 2025 · Sep 30, 2025 −$1.31
Eps Basic Q3 2025 · Sep 30, 2025 −$5.23
Eps Basic Q3 2025 · Sep 30, 2024 −$2.18
Eps Basic restated Q3 2025 · Sep 30, 2024 −$5.24
Sga Expense Q3 2025 · Sep 30, 2025 $2.04M
Sga Expense Q3 2025 · Sep 30, 2025 $6.96M
Sga Expense Q3 2025 · Sep 30, 2024 $1.67M
Sga Expense Q3 2025 · Sep 30, 2024 $4.01M
Rd Expense Q3 2025 · Sep 30, 2025 $688.47K
Rd Expense Q3 2025 · Sep 30, 2025 $3.43M
Rd Expense Q3 2025 · Sep 30, 2024 $784.65K
Rd Expense Q3 2025 · Sep 30, 2024 $2.67M
Net Income Q3 2025 · Sep 30, 2025 −$2.69M
Net Income Q3 2025 · Sep 30, 2025 −$10.2M
Net Income Q3 2025 · Sep 30, 2024 −$2.41M
Net Income Q3 2025 · Sep 30, 2024 −$6.46M
Operating Income Q3 2025 · Sep 30, 2025 −$2.73M
Operating Income Q3 2025 · Sep 30, 2025 −$10.4M
Operating Income Q3 2025 · Sep 30, 2024 −$2.46M
Operating Income Q3 2025 · Sep 30, 2024 −$6.68M